clinical AI
HIMSS24
Industry leaders and insiders discuss how artificial intelligence will transform healthcare in 2024 and beyond at this year's HIMSS Global Health Conference & Exhibition in Orlando.
HIMSS24
Associate professor of biomedical informatics and pediatric endocrinology at Vanderbilt University Medical Center Dr. Yaa Kumah-Crystal talks about improving clinical documentation programs.
Lars Maaløe, chief technology officer and cofounder of Corti, discusses the company's provider-facing AI technology, which can help with clinical documentation by providing real-time feedback while listening to healthcare communications.
DAX copilot will be embedded into Epic systems and use generative AI to help providers focus more on patients and less on administrative tasks such as clinical notes.
HIMSS24
Prashant Natarajan, VP of strategy and products at H20.ai, says he is looking forward to discussing generative AI and the patient experience as well as strategies and success stories with fellow HIMSS24 attendees.
Dr. Peter Bonis, chief medical officer at Wolters Kluwer Health, describes the company's AI-enabled software to detect illicit diversion of controlled and non-controlled substances in patient care and the use of AI in its wider portfolio.
HIMSS24
Brenna Loufek, SaMD regulatory affairs manager at Mayo Clinic, discusses her HIMSS24 session on bringing AI-enabled digital health tools built under research into the clinical setting and what she hopes the audience will gain from the discussion.
Dr. Melek Somai, chief technology and product officer at Froedtert & Medical College of Wisconsin Health Network, discusses how Froedtert and Inception Health use genAI, including helping patients with scheduling and navigating healthcare.
Florida Atlantic University Charles E. Schmidt College of Medicine's Harshal Sanghavi and Dr. Manish Gupta describe the framework used when implementing AI in the healthcare system and utilizing the technology for sports medicine.
HIMSS24
Dr. Jonathan Chen, assistant professor at Stanford Center for Biomedical Informatics Research, previews his upcoming HIMSS24 session on the difficulty of pinpointing what is real in AI and the need for cautious optimism when using it.